A large, multi-center study led by Ann & Robert H. Lurie Children’s Hospital of Chicago derived “achievable benchmarks of care” (ABCs) using electronic health record data, which allows… read more.
For decades, Chicago’s South Side neighborhoods have experienced high rates of firearm violence, making speedy access to expert trauma care a matter of life and death. A recent study… read more.
ALK announced that children aged 4 and older living with severe allergies across the EU can now access the first and only needle-free adrenaline treatment for anaphylaxis, after… read more.
The latest, most comprehensive data on the scale of drink spiking in the UK will be presented to the public for the first time at Anglia Ruskin University… read more.
One in ten emergency patients with visible blood in their urine die within three months of presenting at A&E, new research has found. The WASHOUT study, presented today… read more.
New consumer survey findings from the American Heart Association show that nearly six in every ten American adults still incorrectly believe only those with special training should perform… read more.
Alfresa Pharma released Neffy 1 mg and Neffy 2 mg (adrenaline, epinephrine), which are nasal sprays used as emergency supportive therapy to suppress anaphylaxis, to the Japanese market…. read more.
Prompt, individual-based dose assessment is essential to protect people from the negative consequences of radiation exposure after large-scale nuclear or radiological incidents. However, traditional dosimetry methods often require… read more.
TV depictions of out-of-hospital cardiac arrest may mislead viewers about who is most likely to need cardiopulmonary resuscitation (CPR) and where it’s needed, according to new research published today in the American… read more.
A new Ontario-based study finds that children aged three months to two years are more likely to visit the emergency department (ED) within three days after a virtual primary care appointment compared to an in-person visit. While virtual care remains an… read more.
Hansa Biopharma AB announced the submission of a Biologics License Application (BLA) to the FDA for imlifidase. The Company is requesting priority review of the BLA for the… read more.
At any one time, nearly 1 in 5 emergency department patients in the UK is being cared for in corridors, waiting rooms, and other non-standard ‘overflow’ spaces—an approach… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
